profitability

AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand 0
- Uncategorized
- February 9, 2023
AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on December 31 was $1.38, a drop in actual terms of 17% compared
READ MORE

UBS has No Desire to Buy Credit Suisse, Chairman Tells Newspaper 0
- Economy
- January 14, 2023
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank’s Chairman Colm Kelleher said in a interview published on Saturday. The former Morgan Stanley (NYSE:MS) president said he was focused on organic growth rather than acquisitions and expanding its business in the United States as he ruled out any move to buy
READ MORE